|
Body Fat Distribution
|
G03.180.134 |
|
|
Body Composition
|
G03.180 |
|
|
Ethics, Pharmacy
|
N05.350.340.162.875 |
|
|
Protein Structure, Tertiary
|
G02.111.570.820.709.610 |
|
|
Endocrine Disruptors
|
D27.505.696.353 |
|
|
Mucin-4
|
D12.644.360.534 |
|
|
Myristoylated Alanine-Rich C Kinase Substrate
|
D12.644.360.537 |
|
|
D-Ala(2),MePhe(4),Met(0)-ol-enkephalin
|
D12.644.400.575.281.381.500 |
|
|
NLR Proteins
|
D12.644.360.539 |
|
|
Clonal Deletion
|
G12.535.425.120 |
|
|
Wasp Venoms
|
D20.888.065.970 |
|
|
Vertebral Body
|
D000083442 |
[Main portion of the vertebra which bears majority of the weight.
] |
|
Head Movements
|
G11.427.410.478 |
|
|
Schizophyllum
|
B01.300.179.100.750 |
|
|
Trans-Splicing
|
G02.111.760.700.750 |
|
|
Neurofibromin 1
|
D12.776.476.325.150.500.460 |
|
|
ras GTPase-Activating Proteins
|
D12.776.476.325.150.500 |
|
|
Factor V Deficiency
|
C15.378.463.300 |
|
|
Phencyclidine
|
D03.383.621.699 |
|
|
Galactogogues
|
D27.505.696.365 |
|
